An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Also called yttrium Y90 ibritumomab tiuxetan.
IDEC-Y2B8
Meaning of IDEC-Y2B8 in English
NCI English Dictionary of Cancer Terms. Английский словарь раковых терминов NCI(Национальный институт злокачественных новообразований). 2012